The role of DOCK2 and its regulatory mechanism in the innate immune system
The role of DOCK2 and its regulatory mechanism in the innate immune system
批准号:
18390154
负责人:
FUKUI Yoshinori
金额:
$11.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neutrophils are highly motile leukocytes and play important roles in the innate immune response to invading pathogens. Neutrophil chemotaxis requires Rac activation, yet the Rac activators functioning downstream of chemoattractant receptors remain to be determined. In this study, we have analyzed the role of DOCK2 in chemotactic response of neutrophils. Although DOCK2-deficient neutrophils moved toward the chemoattractant source, they exhibited abnormal migratory behavior with a marked reduction in translocation speed. In DOCK2-deficient neutrophils, chemoattractant-induced activation of both Rac1 and Rac2 were severely impaired, resulting in the loss of polarized accumulation of F-actin and phosphatidylinositol 3, 4, 5 -triphosphate (PIP3) at the leading edge. On the other hand, we found that DOCK2 associates with PIP3 and translocates to the leading edge of chemotaxing neutrophils in a phosphatidylinositol 3-kinase (PI3K) -dependent manner. These results indicate that during neutrophil chemotaxis DOCK2 regulates leading edge formation through PIP3-dependent membrane translocation and Rac activation. In addition to this, we revealed that DOCK2 is a Rac activator critical for migration of plasmacytoid dendritic cells. Our results thus indicate that DOCK2 plays an important role not only in the acquired, but also in the innate immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shignella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery
Shignella IpgB1 促进细菌通过 ELMO-Dock180 机器进入
DOI:
--
发表时间:
2007
期刊:
Nature Cell Biology 9
影响因子:
--
作者:
[Handa, Y., et. al.]
通讯作者:
et. al.
The role of DOCK2 in neutrophil chemotaxis.
DOCK2 在中性粒细胞趋化中的作用。
DOI:
--
发表时间:
2006
期刊:
Jikken-igaku 24
影响因子:
--
作者:
[Y., Fukui]
通讯作者:
Fukui
好中球遊走を制御するRac活性化分子DOCK2
DOCK2,一种控制中性粒细胞迁移的 Rac 激活分子
DOI:
--
发表时间:
2006
期刊:
実験医学 24
影响因子:
--
作者:
[岡崎 拓, 本庶 佑, 周岡 拓, Nombela-Arrieta C et al., Handa Y et al., Nombela-Arrieta C et al., Handa Y et al., Nombela-Arrieta C et al., Handa Y et al., Gercia-Bernal D et al., Kunisaki Y et al., Shulman Z et al., Kunisaki Y et al., 福井宣規]
通讯作者:
福井宣規
IL-4受容体のメンブレントラフィックを介したDOCK2-RacシグナルによるCD4^+T細胞Iineage commitment制御機構の解明
DOCK2-Rac 信号通过 IL-4 受体膜运输阐明 CD4^+ T 细胞谱系承诺的控制机制
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[田中 芳彦, 他]
通讯作者:
他
DOI:
10.1182/blood-2006-04-017608
发表时间:
2006-10-01
期刊:
BLOOD
影响因子:
20.3
作者:
[Shulman, Ziv, Pasvolsky, Ronit, Alon, Ronen]
通讯作者:
Alon, Ronen
共 18 条
Signaling and functions of CDM family proteins that acts as Rac GEFs
-
批准号:22247017
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$27.54万
-
财政年份:2010
-
负责人:FUKUI Yoshinori
-
依托单位:
Role of the phosphatidylserine receptor in development of hematopoietic cells
-
批准号:16390144
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2004
-
负责人:FUKUI Yoshinori
-
依托单位:
Role of the CDM family proteins in the immune surveillance.
-
批准号:16043239
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$25.34万
-
财政年份:2004
-
负责人:FUKUI Yoshinori
-
依托单位:
Role of the CDM family protein DOCK2 in lymphocyte functions
-
批准号:14370113
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2002
-
负责人:FUKUI Yoshinori
-
依托单位:
Identification of the ligand recognized by a mAb specific for CD4^+CD8^+ thymocyte
-
批准号:11670325
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1999
-
负责人:FUKUI Yoshinori
-
依托单位:
Molecular basis for T cell repertoire selection in the thymus
-
批准号:11694289
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1999
-
负责人:FUKUI Yoshinori
-
依托单位:
Molecular analysis for TCR-MHC-peptide interaction in thymic selection in vitro and in vivo
-
批准号:08839017
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:FUKUI Yoshinori
-
依托单位:
海外基金